HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Zhao Selected Research

pseudokobusine

4/2015Evaluation of Aconitum diterpenoid alkaloids as antiproliferative agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Zhao Research Topics

Disease

168Neoplasms (Cancer)
12/2022 - 12/2003
38Infections
08/2022 - 01/2005
28Inflammation (Inflammations)
12/2022 - 01/2005
24Scoliosis
01/2022 - 08/2004
22Breast Neoplasms (Breast Cancer)
12/2022 - 07/2011
21Pain (Aches)
08/2022 - 07/2008
18Prostatic Neoplasms (Prostate Cancer)
10/2022 - 01/2014
17Neoplasm Metastasis (Metastasis)
01/2022 - 04/2007
16Carcinogenesis
01/2022 - 09/2004
14Body Weight (Weight, Body)
06/2022 - 11/2009
14Leukemia
01/2022 - 03/2001
13Fibrosis (Cirrhosis)
04/2022 - 06/2013
13Wounds and Injuries (Trauma)
01/2022 - 02/2007
13Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2007
12Hypoxia (Hypoxemia)
01/2021 - 08/2010
11Nasopharyngeal Carcinoma
09/2022 - 06/2005
11Insulin Resistance
04/2022 - 05/2007
10Hypertension (High Blood Pressure)
04/2022 - 08/2010
10Carcinoma (Carcinomatosis)
02/2022 - 12/2003
10Congenital Abnormalities (Deformity)
01/2022 - 04/2012
10COVID-19
01/2022 - 01/2020
10Hepatitis B
08/2018 - 01/2005
9Alzheimer Disease (Alzheimer's Disease)
08/2022 - 09/2012
9Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 11/2015
9Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 02/2004
9Non-alcoholic Fatty Liver Disease
06/2022 - 09/2013
9Necrosis
01/2022 - 01/2013
9Thrombosis (Thrombus)
10/2021 - 09/2010
8Cognitive Dysfunction
06/2022 - 01/2010
8Hemorrhage
05/2022 - 01/2013
8Reperfusion Injury
03/2022 - 04/2012
8Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2015
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2005
8Hepatocellular Carcinoma (Hepatoma)
12/2020 - 11/2008
8Pathologic Processes
10/2020 - 04/2007
8Lung Neoplasms (Lung Cancer)
10/2020 - 12/2005
8Colonic Neoplasms (Colon Cancer)
08/2015 - 06/2006
7Ischemic Stroke
08/2022 - 07/2008
7Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2013
7Osteoarthritis
01/2021 - 05/2008
7Cicatrix (Scar)
01/2020 - 09/2009
6Liver Diseases (Liver Disease)
12/2022 - 01/2009
6Stroke (Strokes)
12/2022 - 04/2017
6Bacterial Infections (Bacterial Infection)
01/2022 - 05/2014
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 12/2007
6Multiple Myeloma
03/2021 - 06/2010
6Hematologic Neoplasms (Hematological Malignancy)
03/2021 - 02/2005
6Spinal Cord Injuries (Spinal Cord Injury)
07/2020 - 11/2008

Drug/Important Bio-Agent (IBA)

86Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2002
38Pharmaceutical PreparationsIBA
01/2022 - 02/2004
37Biomarkers (Surrogate Marker)IBA
03/2022 - 05/2006
22Biological ProductsIBA
06/2022 - 04/2007
19DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2003
17Therapeutic UsesIBA
06/2022 - 11/2007
16Glucose (Dextrose)FDA LinkGeneric
06/2022 - 08/2015
15CytokinesIBA
12/2021 - 05/2007
14VaccinesIBA
01/2022 - 05/2009
14MicroRNAs (MicroRNA)IBA
04/2021 - 03/2009
13AntibodiesIBA
06/2022 - 05/2009
12LipidsIBA
06/2022 - 06/2009
12EnzymesIBA
01/2022 - 08/2004
12Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2007
12Messenger RNA (mRNA)IBA
08/2021 - 02/2012
11Small Interfering RNA (siRNA)IBA
01/2022 - 05/2009
11Long Noncoding RNAIBA
12/2021 - 09/2014
10Peptides (Polypeptides)IBA
01/2022 - 02/2008
9CollagenIBA
01/2022 - 03/2010
9PolymersIBA
09/2021 - 08/2014
9LigandsIBA
01/2021 - 01/2013
8HydrogelsIBA
08/2022 - 05/2014
8RNA (Ribonucleic Acid)IBA
06/2022 - 08/2015
8Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 08/2012
8AcidsIBA
01/2021 - 06/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 05/2011
7salicylhydroxamic acid (SHAM)IBA
12/2022 - 03/2010
7AntioxidantsIBA
09/2022 - 04/2012
7Phosphotransferases (Kinase)IBA
01/2022 - 05/2008
6Transcription Factors (Transcription Factor)IBA
04/2022 - 08/2010
6AntigensIBA
01/2022 - 12/2003
6LipopolysaccharidesIBA
12/2021 - 10/2018
6Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2014
6Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020 - 08/2010
6Hormones (Hormone)IBA
01/2020 - 03/2010

Therapy/Procedure

90Therapeutics
10/2022 - 02/2004
21Drug Therapy (Chemotherapy)
01/2022 - 12/2005
14Electroacupuncture
10/2020 - 11/2010
13Radiotherapy
09/2022 - 06/2005
13Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 10/2008
10Immunotherapy
01/2022 - 04/2007
9Transplantation
06/2021 - 02/2005
8Castration
10/2022 - 01/2014
8Aftercare (After-Treatment)
02/2022 - 07/2008
8Stents
01/2022 - 07/2013
8Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
05/2019 - 02/2003
7Chemoradiotherapy
02/2022 - 04/2016
7Osteotomy
01/2022 - 09/2009
7Hematopoietic Stem Cell Transplantation
04/2016 - 04/2012
6Lasers (Laser)
05/2021 - 01/2018
6Length of Stay
03/2021 - 12/2013
6Catheters
07/2020 - 01/2016